Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Dr. Gillis' Wellness Center vs Invyncible

Dr. Gillis' Wellness Center
Graded #177

Higher grade

vs+6
Invyncible
Graded #303

Lower grade

The verdict

Dr. Gillis' Wellness Center takes it — 67/100 to 61/100.

Dr. Gillis' Wellness Center grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Dr. Gillis' Wellness Center is a Maine-based clinic (Oakland) offering nationwide telehealth for GLP-1 weight loss. It prescribes semaglutide, tirzepatide, and retatrutide in both injectable and subli

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDr. Gillis' Wellness Center +9
64
55
Dose & formulationDr. Gillis' Wellness Center +4
68
64
Clinical oversightDr. Gillis' Wellness Center +14
84
70
Labs & monitoringDr. Gillis' Wellness Center +1
53
52
FulfillmentDr. Gillis' Wellness Center +16
81
65
Contract termsInvyncible +24
37
61
Dr. Gillis' Wellness Center · left barInvyncible · right bar

The numbers

MetricDr. Gillis' Wellness CenterInvyncible
WeighScore67/10061/100
GradeCC
Scorecard rank#177#303
Semaglutide$149/mo (starting dose, compounded)$192/mo (0.5 mg dose, compounded)
TirzepatideNot disclosed$210/mo (compounded)
CoverageAll 50 states40 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesInjection only

Strengths

  • Sublingual ODT tablets offered as needle-free alternative
  • Broad GLP-1 menu: semaglutide, tirzepatide, and retatrutide
  • Transparent pricing: $150 starting dose, plans from $149/mo
  • Led by board-certified physician/surgeon with 25+ years experience
  • No contracts; flexible weekly, bi-weekly, or monthly cadence

Where it loses points

  • Specific dose-tier pricing beyond starting plan not detailed
  • Compounded vs brand not explicitly stated for all meds
  • Smaller clinic vs national telehealth brands
  • State licensing list not published
Invyncible

Graded #303 · C

Strengths

  • Corporate parent disclosed (Nationwide Telemedicine, LLC) — better than most competitors hiding behind trade names
  • Physical corporate address published (St. Petersburg, FL)
  • LegitScript verification seal displayed
  • No long-term commitment required
  • Offers both semaglutide and tirzepatide programs

Where it loses points

  • Pricing not disclosed on the public site — fully gated behind signup
  • Drug forms (compounded vs brand, injection vs oral) not disclosed
  • 503A vs 503B designation not specified
  • Pharmacy partner not named
  • States served not listed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard